|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
|
Investment
TeamInvestment Professionals Boston Edward L. Cahill - Partner San Francisco Martin R. Felsenthal - Partner Administration |
Enrico Picozza is a pioneer in life sciences technology with a history of recognizing and developing new technologies that change markets. Prior to joining HLM, Enrico co-founded HTS Biosystems, Inc., an early developer of SPR detection systems, where he served as Chief Operating Officer and Chief Technology Officer. Prior to HTS, Enrico held leadership positions with PerkinElmer, Inc. and Applied Biosystems, Inc. At Applied Biosystems, Enrico was one of the major forces behind the development and commercialization of PCR, the revolutionary DNA-replicating technology that enabled the development of some of the most significant advancements in molecular biology. He is the holder of nine patents and has been recognized by the Smithsonian Institute for his achievements in PCR. Enrico is the author of numerous scientific papers and is a frequent speaker on molecular biology. He earned his masters degree in molecular and cell biology from the University of Connecticut. Enrico Picozza can be reached at epicozza@hlmvp.com
|